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Background: MicroRNAs are small non-coding RNAs involved in gene expression regulation by targeting specific
regions in the 3′-UTR of the mRNA of their target genes. This binding leads to a decrease in the protein levels of
such genes either by mRNA degradation or mRNA destabilization and translation inhibition. The interaction between a
miRNA and its target mRNAs is usually studied by co-transfection of a reporter expression vector containing the 3′-UTR
region of the mRNA and an inhibitory or precursor molecule for the miRNA. This approach, however, does not measure
the direct and physical interaction between a miRNA and a specific mRNA.
Findings: RNA molecules corresponding to miR-224 and to the 3′-UTR of SLC4A4 were incubated together and their
interaction studied under different binding conditions using electrophoretic mobility shift assays. A direct and specific
interaction between miR-224 and SLC4A4 mRNA was observed. This interaction was abolished in the presence of
competitors.
Conclusions: In this study, we explored a new application for the electrophoretic mobility shift assay and we
demonstrated that it is a useful alternative method to assess, in a direct and specific manner, whether a miRNA binds
to a specific predicted target mRNA.
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MiRNAs are a new class of small, non protein-encoding
RNAs [1,2] responsible for gene expression regulation at
a post-transcriptional level. MiRNAs recognize and bind
to the 3′-UTR of the mRNA of their target genes. Only
6-7nt of the miRNA (miRNA seed) are complementary
to the target mRNA. Imperfect base pairing between
miRNAs and their target mRNAs leads to repression of
translation and/or deadenylation, followed by destabili-
zation of the target [3]. Many cellular pathways are regu-
lated by miRNAs such as development, proliferation,
differentiation, cell fate determination, apoptosis, signal
transduction, organ development, host-viral interactions
and tumorigenesis [4]. MiRNAs play key roles in the
pathogenesis of cancer and many miRNAs have been
shown to function as either oncomirs or tumor suppressors
[5-11] (for review see [12]). Furthermore, miRNAs have
an important role in the development of chemosensitivity* Correspondence: cciudad@ub.edu
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reproduction in any medium, provided the oror chemoresistance in different types of cancer (summa-
rized in [13]). The prediction of target genes for a given
miRNA is carried out using bioinformatic algorithms that
require experimental validation. The interaction of the
miRNA target gene with a specific miRNA is usually
studied by co-transfection of an inhibitory molecule
(anti-miR) or miRNA precursor molecule together with
a reporter vector containing the 3′-UTR region of the
gene. Although this method suggests a physical and
functional interaction, it does not prove a direct inter-
action of the target gene with the miRNA [14]. More
complex methods based on immunoprecipitation of the
complex miRNA/mRNA have been used to address this
issue [15,16].
In a previous study, we studied the role of miR-224
in methotrexate resistance in HT-29 colon cancer
cells. The underexpression of miR-224 resulted in a
decrease in MTX sensitivity and an increase in the
mRNA levels of three genes (CDS2, HSPC159 and
SLC4A4) whose role in MTX resistance was also func-
tionally validated. After confirming within the cell that
miR-224 was functionally regulating these three genes,. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Sequences of all the molecules used for the
binding assays
Molecule Sequence
miR-224 3′ UUGCCUUGGUGAUCACUGAAC 5′
SLC4A4 3′-UTR 5′ AAGCUUUCUAUUGUGACUUU 3′
anti-miR-224 5′ A*A*C*GGAAC*C*AC*T*AGT*GAC*T*T*G 3′
anti-miR-13MIS 5′ T*T*G*CCT AC*CAC*T*ACAC*T*G*A*A*G 3′
SLC4A4 3′-UTR-MM 5′ AAGCUUUCUAUUCACUGAAU 3′
Sequences of the RNA and DNA molecules used in this study. For antisense
oligodeoxynucleotides, phosphorothioate-modified bonds were designed
according to the minimal modification criteria [21] and are indicated as *.
Mismatch bases are indicated in italics.
Figure 1 Binding between miR-224 and the 3′-UTR of the gene SLC4A
3 correspond to the incubation of the probe with increasing concentration
incubation of the probe with increasing concentrations (3 and 10 μM) of m
probe with tRNA and lanes 8 and 9 correspond to the probe alone, for dup
measured by the increase in the intensity of the band corresponding to m
with respect to the total radioactivity in each lane after quantification with
miR-224 conformations.
Solé et al. BMC Research Notes 2013, 6:454 Page 2 of 7
http://www.biomedcentral.com/1756-0500/6/454we validated the direct and physical interaction be-
tween miR-224 and CDS2, HSPC159 or SLC4A4 using
binding assays [17].
EMSA or electrophoretic mobility shift assays are
widely used to confirm the binding of a nucleic acid to
a protein or another nucleic acid [18-20]. However,
there have been no reports regarding the use of EMSA
to study the interaction of a miRNA with its target.
Therefore, we propose EMSA as an alternative method to
validate in a direct and specific fashion whether or not a
miRNA binds to its target genes. This study describes the
experiments carried out to develop this methodology.4. (A) Lane 1 corresponds to the probe alone (miR-224*), lanes 2 and
s of SLC4A4 3′-UTR (3 and 10 μM), lanes 4 and 5 correspond to the
utant SLC4A4 3′-UTR, lane 7 corresponds to the incubation of the
licate, on a denaturing gel. In the lower panel, the binding is
iR-224*:SLC4A4 3′-UTR and it is expressed as the percentage of intensity
ImageQuant software. (B) Structure prediction of
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Materials
For binding assays, the following molecules were used:
miR-224, RNA sequence corresponding to the mature
form of miRNA-224; SLC4A4 3′-UTR, a 20-mer RNA
sequence for the 3′-UTR corresponding to SLC4A4
bearing the target site for miR-224; SLC4A4 3′UTR-MM,
a negative control 3′UTR sequence for the SLC4A4 RNA,
bearing 6 mismatches in the target site for miR-224,
anti-miR-224, a modified antisense oligodeoxynucleo-
tide complementary to the sequence of the mature form
of miR-224; and anti-miR-13MIS, antisense oligodeoxynu-
cleotides containing 13 mismatches, compared to anti-
miR-224.Figure 2 Binding and competition between 3′-UTR of the gene SLC4A
3′-UTR*) and the other lanes (2–7) correspond to the incubation of the pro
corresponds to the mismatch probe SLC4A4 3′UTR-MM* alone, lanes 9 and
intensity of the bands was quantified with ImageQuant software. Integrate
between SLC4A4 3′-UTR*:miR-224 (white bars) and the disappearance of th
to the percentage of intensity of each band with respect to the total radio
(B) The binding between SLC4A4 3′-UTR* and miR-224 was competed with
was incubated with miR-224 either in the absence (lane 2) or the presence
(3× the concentration of miR-224). The intensity of the bands was quantifie
corresponding decrease in the binding between SLC4A4 3′-UTR*:miR-224 (
3′-UTR* alone (white bars). Values correspond to the percentage of intensitThe sequence corresponding to the 3′-UTR of the gene
was 20 nucleotides long to allow better visualization of
the shifted band, to be more specific and to avoid second-
ary structures that longer sequences might acquire, and
that most likely would interfere with the analysis.
All RNA and DNA oligonucleotides were purchased
from Sigma-Aldrich (Madrid, Spain) and their specific
sequences are listed in Table 1.
Binding assays
Radiolabelled probes (20 000 cpm, [32P]) were incubated
for 30 minutes at 37°C with the corresponding RNA or
DNA molecules in the presence of 10 mM MgCl2,
100 mM NaCl, 50 mM HEPES pH 7.2 (AppliChem,4 and miR-224. (A) Lane 1 corresponds to the probe alone (SLC4A4
be with increasing concentrations of miR-224 (1nM-300nM). Lane 8
10 correspond to its incubation with miR-224 (100 and 300nM). The
d in the panel below, it is represented the increase in the binding
e band corresponding to SLC4A4 alone (grey bars). Values correspond
activity in each lane. Probes and shifted bands are indicated by arrows.
unlabeled SLC4A4 3′-UTR and SLC4A4 3′-UTR-MM. SLC4A4 3′-UTR*
(lanes 3 and 4) of SLC4A4 3′-UTR and SLC4A4 3′-UTR-MM, respectively
d with ImageQuant software. In the panel below, it is represented the
gray bars) and the increase of the band corresponding to SLC4A4
y of each band relative to the total radioactivity in each lane.
Solé et al. BMC Research Notes 2013, 6:454 Page 4 of 7
http://www.biomedcentral.com/1756-0500/6/454Ecogen, Barcelona, Spain) and 5% Glycerol (Sigma-
Aldrich, Madrid, Spain). Binding reactions were run in a
12% polyacrylamide gel (10 mM MgCl2, 5% Glycerol,
50 mM HEPES, pH 7.2) for 4 h at 190 V (4°C). Samples
for denaturing gels were heated at 95°C for 5 min in
loading buffer containing 95% formamide before electro-
phoresis in 5% polyacrylamide gels (1xTBE plus 8 M
urea).
Gels were dried for 90 minutes at 80°C, exposed over-
night to Europium plates and scanned in a Storm 840
scanner (Molecular Dynamics, GE Healthcare, Barcelona,
Spain).
MiRNA secondary structure prediction
The miR-224 secondary structures were predicted using
the mfold program, v2.3, (http://mfold.rna.albany.edu/?
q=mfold) [22]. This program determines the optimal
and suboptimal secondary structures of RNA calculated
for a 1 M NaCl solution at 37°C. The prediction was
performed with the suboptimality parameter set at 5% so
that it shows all the structures that have a free energy of
formation of up to 5% higher than the optimal.
Findings and discussion
The first set of binding assays was performed using the
radiolabeled miRNA-224 sequence (miR-224*) as the
probe. MiR-224* displays two bands (Figure 1A, lane 1),
one with higher mobility (band 1) and another band
with lower mobility (band 2). When miR-224* was incu-
bated with increasing concentrations of the 3′-UTR re-
gion of the gene SLC4A4 (3 and 10 μM) we could
observe the formation of a third band with lowerFigure 3 Binding between miR-224 and anti-miR-224. The probe miR-2
4–5) at the specified concentrations. Probes and shifted bands are indicate
ing of the miR-224 to its anti-miR-224 by perfect matching, or to the negaelectrophoretic mobility. This third band corresponds to
the specific binding of the two molecules miR-224*:
SLC4A4 3-UTR (Figure 1A, lanes 2 and 3) since it is not
formed with SCL4A4 3′UTR-MM (lanes 4 and 5). Band
number 1 switched to band number 2 in the presence of
SLC4A4 3′-UTR, either the wild type or the mutant se-
quence. The conformation with faster electrophoretic
mobility also disappeared in the presence of tRNA (lane
7). These results indicate that the upper band (lanes 2 and
3) represents the specific binding between miR-224 and
SLC4A4 3′-UTR, rather than a multicomplex. MiR224
alone was also run on a denaturing gel to test whether or
not the two bands present in native gels were two confor-
mations of the same miRNA. As shown in Figure 1A (lanes
8 and 9), only one band was observed.
Thus, in vitro, miR-224 alone takes at least two con-
formations with different mobility. Structure prediction
using the mfold software [22] showed different confor-
mations with free energies of ΔG= −0.30 and ΔG= 0.20
(Figure 1B), indicating plasticity in the molecule. There-
fore, the secondary structure of miRNA may alternate
between conformations.
The binding of miR-224 to its target gene was also
confirmed using as radiolabeled probe the sequence cor-
responding to the 3′-UTR of SLC4A4 (Figure 2A, lanes
1–7). When using SCL4A4 3′-UTR-MM sequence, the
binding with miR-224 was not observed (Figure 2A,
lanes 9 and 10). These results proved that miR-224 binds
specifically to the 3′-UTR sequence of its target SLC4A4.
Indeed, the experiments involving labeled 3′UTRs gave an
easier read-out to understand (Figures 2A and 2B), where
the bands appeared more defined and the proportion of24* was incubated with anti-miR-224 (lanes 2–3), anti-miR-13MIS (lanes
d by arrows. To the right it is represented a diagram showing the bind-
tive control anti-miR-13MIS.
Figure 4 Competition assay. The binding between miR-224 and SLC4A4 3′-UTR was competed with increasing concentrations of unlabeled
anti-miR-224. Probe miR-224* was incubated with SLC4A4 3′-UTR either in the presence (lanes 6–8) or the absence of anti-miR-224 (lane 2). Lanes
3–5 represent the binding between miR-224* and anti-miR-224. The intensity of the bands was quantified with ImageQuant software and normal-
ized against the total radioactivity in each lane. It is represented the corresponding decrease in the binding between miR-224*:SLC4A4 3′-UTR,
and it is expressed as a percentage of the control (lane 2) (lower panel).
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interaction of miR-224 with SCL4A 3′UTR in vitro.
To complete the usefulness of the assay we performed
competition experiments of the interaction between
miR-224 and SCL4A4 3′-UTR*. As shown in Figure 2B,
this interaction was competed by wild type SCL4A4 3′-
UTR but not by a mutated version of the sequence
(mismatch).
When miR-224 was used as the probe, the necessary
concentration of the corresponding unlabeled SLC4A4
3′-UTR sequence for the formation of the binding was
3 μM (Figure 1A, lane 2). However, when using SLC4A4
3′-UTR as the probe the necessary concentrations for the
formation of such duplexes ranged from 10 to 300 nM of
cold miR-224 (Figure 2A), therefore suggesting that the
binding of miR-224 to a radiolabeled SLC4A4 3′-UTR
is stronger and more specific than using miR-224 as
probe.
Next, miR-224 was incubated with anti-miR-224, the
molecule used to successfully inhibit miR-224 function,
and with the corresponding negative control used in
functional assays, anti-miR-13MIS. This anti-miR con-
tains 7 mismatches located in the miR-224 seed region
and 6 additional mismatches in its 3′ region. As can be
observed in Figure 3, miR-224 was bound by anti-miR-
224 forming the corresponding miR-224*:anti-miR-224
duplex (lanes 2–3). A major band appeared between
bands 1 and 2 of miR-224 alone (lane 1) and a more re-
tarded band that might correspond to a different con-
formation of the duplex miR-224*:anti-miR-224. It is
interesting to note that anti-miR-224 was also able to
bind to the band number 2 of the probe alone corre-
sponding to folded miR-224, at variance of SLC4A4 3′-
UTR. This difference can be explained by the fact that
anti-miR-224 is completely complementary to miR-224,
in contrast to SLC4A4 3′-UTR, which has only 7nt
complementary to the miRNA (miRNA seed). Therefore,
anti-miR-224 can unfold miR-224* and form the ob-
served duplex.
The effect of incubating miR-224 with anti-miR-13MIS
can be observed in lanes 4 and 5 (Figure 3), showing that
it is not able to bind miR-224, since it presents 13 mis-
matches with respect to miR-224, confirming its validity
as a negative control.
Figure 4 shows the binding of miR-224* to SLC4A4
3′-UTR (lane 2) and the formation of the duplex miR-
224*:anti-miR-224 after incubation with increasing con-
centrations of anti-miR-224 (lanes 3–5). In this case, the
band pattern observed was the same as the one in Figure 3
(lanes 2 and 3). When competition experiments were per-
formed in the presence of miR-224*, 3′-UTR SLC4A4 and
anti-miR-224, it was observed that increasing concentra-
tions of anti-miR-224 were able to displace the binding of
miR-224* to the 3′-UTR of the gene SLC4A4. This wasevidenced by the disappearance of the upper band corre-
sponding to the binding of miR-224*:SLC4A4 3′-UTR
(Figure 4, lanes 6–8 compared to lane 2). The competition
between anti-miR-224 and SLC4A4 3′-UTR for the
binding to miR-224* was also evidenced by the fact that
higher concentrations of anti-miR-224 were needed to
completely bind to miR-224 (lanes 6–7 compared to
lanes 3–4).
Conclusions
The results presented in this study show that EMSA is
an easy, useful tool to validate in a direct and specific
manner the interaction between a given miRNA and a
determined cellular target mRNA, specially when using
as probe the target 3′-UTR sequence rather than the
miRNA. Using two synthetic RNA molecules corre-
sponding to the mature form of a miRNA and to a frag-
ment of the 3′-UTR region of a predicted target mRNA,
this assay provides a view of the direct physical inter-
action between these two molecules.
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